Clinical Hypertension
Scope & Guideline
Advancing hypertension research for a healthier tomorrow.
Introduction
Aims and Scopes
- Clinical Management of Hypertension:
This area examines various interventions, treatments, and management strategies for hypertension, including pharmacological therapies, lifestyle modifications, and novel approaches such as the use of artificial intelligence. - Epidemiological Studies:
Research focusing on the prevalence, risk factors, and outcomes associated with hypertension in different populations, including children, adolescents, and specific demographic groups. - Pathophysiological Mechanisms:
Exploration of the biological and physiological mechanisms underlying hypertension, including genetic, metabolic, and environmental factors. - Guideline Development and Implementation:
The journal publishes updates and consensus documents related to clinical guidelines for hypertension diagnosis and treatment, reflecting best practices and evidence-based recommendations. - Innovative Measurement Techniques:
Investigation into new methods for measuring blood pressure, including the use of ambulatory monitoring and cuffless devices, to improve accuracy and patient adherence.
Trending and Emerging
- Hypertension in Special Populations:
There is a growing focus on understanding hypertension in specific groups such as children, adolescents, women during pregnancy, and populations with unique health challenges. - Integration of Technology in Hypertension Management:
Research exploring the use of wearable devices and telemedicine for hypertension monitoring and management is on the rise, reflecting a shift towards more personalized and accessible healthcare. - Impact of Comorbidities on Hypertension Outcomes:
Increasing attention is being paid to how conditions such as diabetes, obesity, and sleep apnea interact with hypertension, emphasizing the need for comprehensive management strategies. - Artificial Intelligence and Machine Learning Applications:
The application of AI and machine learning in predicting hypertension outcomes and personalizing treatment plans is an emerging area of interest, reflecting advancements in technology. - Longitudinal Studies and Clinical Trials:
An increase in long-term studies evaluating the outcomes of hypertension interventions, including pharmacological treatments and lifestyle changes, is evident, providing richer data for clinical practice.
Declining or Waning
- Traditional Lifestyle Interventions:
Research on basic lifestyle interventions, such as simple dietary recommendations, has seen a reduction as more complex and multifaceted approaches gain interest. - Single-Factor Risk Assessments:
Studies focusing solely on individual risk factors for hypertension without considering their interactions or the broader context of comorbidities are becoming less common. - General Hypertension Awareness Campaigns:
While public health campaigns remain important, there is a noticeable shift towards more specific, targeted studies that assess the impact of these campaigns rather than general awareness.
Similar Journals
BLOOD PRESSURE
Empowering professionals with evidence-based cardiovascular findings.BLOOD PRESSURE is a distinguished journal published by Taylor & Francis Ltd in the field of cardiology and internal medicine, with an ISSN of 0803-7051 and E-ISSN of 1651-1999. Since its inception in 1992, it has become a vital source of research and clinical information, dedicated to advancing our understanding of blood pressure-related health issues. With a notable categorization of Q3 in Cardiology and Cardiovascular Medicine and Q2 in Internal Medicine as of 2023, this journal exemplifies a commitment to evidence-based findings that impact clinical practice and patient care. The journal facilitates a platform for original research, reviews, and case studies, aiming to bridge the gap between researchers and practitioners. Although it does not currently offer open access, BLOOD PRESSURE remains an essential resource for professionals and students alike, striving to enhance health outcomes through dedication to innovative cardiovascular research.
Minerva Cardiology and Angiology
Shaping the future of cardiovascular health through scholarship.Minerva Cardiology and Angiology, published by EDIZIONI MINERVA MEDICA, is a prominent journal in the field of cardiology and cardiovascular medicine, with an ISSN of 2724-5683 and E-ISSN of 2724-5772. Established in 2021, this journal aims to foster the dissemination of cutting-edge research, clinical practice guidelines, and innovative methodologies relevant to cardiovascular health. As of 2023, it holds a commendable Q3 quartile rank in its category, reflecting its growing influence within the scientific community. The journal is indexed in Scopus, where it ranks #221 out of 387 in its field, placing it in the 43rd percentile overall. Although it currently does not offer Open Access options, articles published in Minerva Cardiology and Angiology contribute significantly to ongoing discussions and advancements in heart and vascular health. The journal serves as an invaluable resource for researchers, healthcare professionals, and students seeking to stay informed on the latest developments in cardiology.
CARDIOVASCULAR RESEARCH
Advancing the frontiers of cardiovascular science.CARDIOVASCULAR RESEARCH, published by Oxford University Press, is a premier academic journal dedicated to the evolving field of cardiology and cardiovascular medicine. With a remarkable impact factor reflecting its significant contribution to the scientific community, this journal maintains a Q1 ranking in both Cardiology and Physiology categories, demonstrating its commitment to publishing high-quality research that influences clinical practices and healthcare outcomes. Established in 1967, the journal has consistently provided a platform for innovative studies and reviews, aiming to advance our understanding of cardiovascular physiology and pathology. Researchers, professionals, and students will find published articles crucial for their work, as the journal covers a broad spectrum of topics including molecular biology, genetics, and clinical studies. While currently not offering open access options, CARDIOVASCULAR RESEARCH remains accessible through institutional and individual subscriptions, ensuring that the latest findings are available to those in the cardiovascular science community.
European Respiratory Review
Unveiling the Future of Pulmonary ResearchEuropean Respiratory Review is a prestigious peer-reviewed journal published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, specializing in the dynamic field of pulmonary and respiratory medicine. With an impact factor that places it among the top quartile journals in its category (Q1), as indicated by its impressive Scopus rank of #7 out of 155, it serves as a critical platform for disseminating high-quality research and innovative reviews in the field. As an Open Access journal since 2005, it ensures that cutting-edge findings are readily available to a global audience, promoting greater transparency and collaboration within the academic community. Published from Switzerland, European Respiratory Review covers a broad spectrum of topics from clinical advancements to emerging trends, making it an essential resource for researchers, healthcare professionals, and students committed to advancing respiratory health. The journal's history, dating back to 1992, reflects a steadfast commitment to fostering scholarly exchange and driving forward the frontiers of knowledge within respiratory medicine.
Clinical Medicine Insights-Cardiology
Empowering Healthcare Through Accessible Cardiology InsightsClinical Medicine Insights-Cardiology is a prestigious open-access journal published by SAGE Publications Ltd, focusing on cutting-edge research in the field of cardiology and cardiovascular medicine. With the ever-evolving landscape of cardiovascular health, this journal serves as a vital platform for disseminating significant findings, clinical practices, and innovative therapies. Established in 2007, it has rapidly gained recognition, currently ranked in the Q2 category for cardiology, positioned at #112 out of 387 in Scopus Rankings, and boasting a commendable 71st percentile. The journal not only emphasizes the integration of recent advancements in clinical and laboratory studies but also aims to bridge the gap between research and practice, making it an essential resource for researchers, healthcare professionals, and students alike. Situated in New Zealand and operating with an open-access model, Clinical Medicine Insights-Cardiology promotes the unrestricted dissemination of knowledge, ensuring that critical insights into cardiovascular medicine are accessible globally.
Current Hypertension Reviews
Exploring the Frontiers of Cardiovascular HealthCurrent Hypertension Reviews, published by Bentham Science Publishers Ltd, stands as a leading journal in the field of internal medicine, particularly focusing on hypertension and related cardiovascular disorders. With an impressive impact factor and ranked #59 out of 167 in the Scopus medicine category, this journal highlights key insights and contemporary research trends from its inception in 2006 to 2024. Its commitment to making high-quality research accessible to the medical community, despite lacking an Open Access option, ensures that it continues to contribute significantly to the scientific discourse surrounding hypertension management and innovative treatments. Researchers, clinicians, and students alike will find valuable resources within its pages, as Current Hypertension Reviews plays a critical role in advancing the understanding and treatment of hypertension, ultimately supporting better health outcomes globally.
CLINICAL AND EXPERIMENTAL HYPERTENSION
Exploring the complexities of hypertensive diseases.Clinical and Experimental Hypertension, published by Taylor & Francis Inc, is a crucial resource in the fields of internal medicine and physiology. With its inaugural publication dating back to 1978, this esteemed journal has successfully merged decades of research, providing a platform for the latest advancements in hypertension studies. Operating without an open access model, it is configured to serve a specialized audience of researchers, clinicians, and students who are dedicated to exploring innovative treatment modalities and understanding the complexities of hypertensive diseases. Ranked in the Q3 category in both Internal Medicine and Physiology, this journal accomplishes a commendable standing in the academic community, exemplified by its Scopus rankings which position it within the median percentile range in its field. By disseminating high-quality research and fostering scientific dialogue, Clinical and Experimental Hypertension plays a pivotal role in shaping contemporary understanding and clinical practices concerning hypertension management.
Current Obesity Reports
Transforming insights into impactful public health strategies.Current Obesity Reports, an esteemed journal published by SPRINGER, serves as a pivotal platform for scholars and practitioners in the field of obesity research. With its ISSN of 2162-4968, this journal has been recognized within the competitive landscape of Medicine & Internal Medicine, achieving a commendable Scopus rank of #11 out of 167, placing it in the top 93rd percentile. Launched in 2012 and covering critical developments in obesity up to 2024, this journal synthesizes innovative research, evidence-based practices, and comprehensive reviews that cater to a diverse audience, from researchers to public health professionals. While currently not offering open access options, it remains dedicated to advancing knowledge and fostering discussions that address the multifaceted issues related to obesity, its public health implications, and treatment methodologies. For those involved in tackling obesity challenges, Current Obesity Reports stands as a vital resource, contributing significantly to the discourse and scholarship in the field.
Journal of Nutrition and Metabolism
Transforming Research into Nutritional ExcellenceJournal of Nutrition and Metabolism, published by HINDAWI LTD, is a prominent peer-reviewed, open-access journal that has been serving the scientific community since 2010. Based in Egypt, this journal is dedicated to advancing the field of nutrition and metabolism, providing a platform for innovative research that spans endocrinology, diabetes, food science, and dietetics. With a consistent commitment to accessibility, it embraces open-access policies to facilitate wider dissemination of knowledge, ensuring that researchers, professionals, and students can freely engage with pivotal studies and findings. The journal is currently indexed with an impressive standing in various categories, including being positioned in Q2 in Food Science and Q3 in Endocrinology, Diabetes and Metabolism. Furthermore, it ranks among the top journals in its fields on Scopus, reflecting its significance and impact within the research community. With a focus on robust, evidence-based studies that inform dietary practices and metabolic health, the Journal of Nutrition and Metabolism plays a crucial role in addressing the challenges of modern nutrition.
KIDNEY & BLOOD PRESSURE RESEARCH
Connecting Researchers to Combat Kidney and Blood Pressure Challenges.Kidney & Blood Pressure Research, published by KARGER, is a premier open-access journal dedicated to the evolving fields of nephrology and cardiovascular medicine. Since its inception in 1978 and with a forward-looking scope extending to 2024, this journal plays a vital role in disseminating innovative research and clinical findings related to kidney health and blood pressure regulation. With an impressive 2023 Impact Factor and ranked in the second quartile (Q2) in both cardiology and nephrology categories, it is recognized as a significant resource among its peers, including a Scopus rank of #23 in Nephrology and #128 in Cardiology. The journal's commitment to open access since 2013 further ensures that cutting-edge research is readily available to the global scientific community. Based in Switzerland, the journal not only fosters academic collaboration but also addresses critical health challenges related to kidney function and hypertension. It is a crucial platform for researchers, healthcare professionals, and students alike, encouraging the ongoing dialogue and advancement of knowledge in these critical areas of health.